DMC Group LLC Has $776,000 Holdings in Axon Enterprise, Inc $AXON

DMC Group LLC cut its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 8.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 937 shares of the biotechnology company’s stock after selling 81 shares during the quarter. DMC Group LLC’s holdings in Axon Enterprise were worth $776,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of AXON. TCTC Holdings LLC increased its position in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after buying an additional 24 shares during the period. Bartlett & CO. Wealth Management LLC increased its position in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after buying an additional 33 shares during the period. Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise during the first quarter worth $31,000. Catalyst Capital Advisors LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth $32,000. Finally, Flaharty Asset Management LLC acquired a new stake in shares of Axon Enterprise during the first quarter worth $33,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $743.64, for a total value of $7,436,400.00. Following the completion of the sale, the chief executive officer owned 3,043,982 shares in the company, valued at $2,263,626,774.48. This represents a 0.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. The trade was a 5.07% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 49,932 shares of company stock worth $37,978,216. 5.70% of the stock is owned by insiders.

Axon Enterprise Stock Performance

AXON opened at $714.60 on Wednesday. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The company’s fifty day moving average price is $757.21 and its two-hundred day moving average price is $710.53. Axon Enterprise, Inc has a 1-year low of $420.49 and a 1-year high of $885.91. The company has a market cap of $56.10 billion, a price-to-earnings ratio of 176.44, a PEG ratio of 28.02 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the prior year, the company posted $1.20 earnings per share. The business’s revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analysts Set New Price Targets

AXON has been the topic of several research analyst reports. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a research note on Tuesday, August 5th. JPMorgan Chase & Co. increased their target price on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 17th. Northland Securities set a $800.00 target price on shares of Axon Enterprise in a research note on Tuesday, August 5th. Wolfe Research initiated coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They set an “outperform” rating on the stock. Finally, Piper Sandler initiated coverage on shares of Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 target price on the stock. Fourteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.